New concepts in chronic XXXX . What is the impact on therapy?

@entity1 @entity2544 @entity565 @entity458 @entity1224
The following management guidelines, based on changing concepts in @entity565 pathogenesis and treatment, outline an approach aimed at reducing @entity565 morbidity and mortality. Use of these guidelines may help to reduce @entity1224 and result in improved care for these @entity1 . Maintain open lines of communication between @entity1 and physician. Promote positive @entity1 -physician interaction. Remain alert for signs of @entity458 . Use maintenance antiinflammatory medications and bronchodilators as needed. Discuss medication requirements and possible side effects. Caution against abuse of beta agonists. Monitor drug diaries and @entity2544 levels to assess medication requirements and compliance with treatment. Monitor daily peak expiratory flow rates in @entity1 prone to severe attacks of @entity565 . Encourage @entity1 to report progressive symptoms or peak expiratory flow rates less than 200 liters/min. For @entity565 uncontrolled by bronchodilators and inhaled antiinflammatory medications, treat promptly with systemic corticosteroids.
